Abstract |
A new class of Aurora-A inhibitors have been identified based on the 2-amino-pyrrolo[2,3-d] pyrimidine scaffold. Here, we describe the synthesis and SAR of this novel series. We report compounds which exhibit nanomolar activity in the Aurora-A biochemical assay and are able to inhibit tumor cell proliferation. This study culminates in compound 30, an inhibitor with potent activity against Aurora A (IC50=0.008 microM), anti-proliferative activity against several tumor cell lines and induces polyploidy in H460 cells.
|
Authors | Kevin J Moriarty, Holly K Koblish, Thomas Garrabrant, Jahanvi Maisuria, Ehab Khalil, Farah Ali, Ioanna P Petrounia, Carl S Crysler, Anna C Maroney, Dana L Johnson, Robert A Galemmo Jr |
Journal | Bioorganic & medicinal chemistry letters
(Bioorg Med Chem Lett)
Vol. 16
Issue 22
Pg. 5778-83
(Nov 15 2006)
ISSN: 0960-894X [Print] England |
PMID | 16949284
(Publication Type: Journal Article)
|
Chemical References |
- Antineoplastic Agents
- Enzyme Inhibitors
- Pyrimidines
- Pyrroles
- Aurora Kinases
- Protein Serine-Threonine Kinases
|
Topics |
- Antineoplastic Agents
(chemical synthesis, pharmacology)
- Aurora Kinases
- Cell Line, Tumor
- Drug Screening Assays, Antitumor
- Enzyme Inhibitors
(chemical synthesis, pharmacology)
- Humans
- Inhibitory Concentration 50
- Polyploidy
- Protein Serine-Threonine Kinases
(antagonists & inhibitors)
- Pyrimidines
(chemical synthesis, pharmacology)
- Pyrroles
(chemical synthesis, pharmacology)
- Structure-Activity Relationship
|